Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
NDRG2 is a member of the N-myc downregulated gene family which belongs to the alpha/beta hydrolase superfamily. Additionally we are shipping NDRG2 Proteins (24) and NDRG2 Kits (8) and many more products for this protein.
Showing 10 out of 95 products:
Human Monoclonal NDRG2 Primary Antibody for ELISA, WB - ABIN566107
Shen, Zhao, Wang, Ji, Liu, Liu, Che, Lin, Li, Zhang, Yao: Immunohistochemical detection of Ndrg2 in the mouse nervous system. in Neuroreport 2008
Show all 16 Pubmed References
Human Polyclonal NDRG2 Primary Antibody for ICC, IF - ABIN4338340
Tepel, Roerig, Wolter, Gutmann, Perry, Reifenberger, Riemenschneider: Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma. in International journal of cancer 2008
Show all 5 Pubmed References
Human Polyclonal NDRG2 Primary Antibody for ELISA, WB - ABIN528174
Araya-Callís, Hiemke, Abumaria, Flugge: Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus. in Psychopharmacology 2012
Show all 2 Pubmed References
Human Polyclonal NDRG2 Primary Antibody for WB - ABIN528175
Wang, Zhong, Li, Peng, Kinden, Liang, Li, Shi, Liu, Wang, Xiong: Electroacupuncture attenuates reference memory impairment associated with astrocytic NDRG2 suppression in APP/PS1 transgenic mice. in Molecular neurobiology 2014
Human Polyclonal NDRG2 Primary Antibody for ELISA, WB - ABIN4338339
Shi, Li, Li, Chen, Wang, Xu, Zhang, Jin, Zhang, Zhao, Song, Feng, Feng, Shen, Yao, Zhao: Expression of NDRG2 in esophageal squamous cell carcinoma. in Cancer science 2010
These findings provide insight into the role of NDRG2 in ischemic-hypoxic injury and provide potential targets for future clinical therapies for stroke.
NDRG2 is a novel ERS-responsive protein and acts as PERK co-factor to facilitate PERK branch, thereby contributing to ERS-induced apoptosis.
Our results show how NDRG2 expression serves as a critical determinant of the invasive and metastatic capacity of oral squamous cell carcinoma (OSCC)
Using double knockout of NDR1 (show STK38 Antibodies) and 2 shows that NDRs acted downstream of MST1 (show MST1 Antibodies) to mediate the egress of mature thymocytes from the thymus, as well as the interstitial migration of naive T cells within popliteal lymph nodes.
The expression level of NDRG2 has a causal influence on mood-related phenotypes.
Ndr1 (show STK38 Antibodies)/2-double null embryos show defects in somitogenesis and cardiac looping, which reveals their essential functions and shows that the NDR (show STK38 Antibodies) kinases are critically required during the early phase of organogenesis
Taken together, our results suggest that the expression of NDRG2 potentially inhibits osteoclast differentiation and plays a role in modulating the signal transduction pathway responsible for osteoclastogenesis.
NDRG2 is associated with decidualization during early pregnancy.
NDRG2 accumulated in skeletal muscle and myoblasts in the absence of TRIM32 (show TRIM32 Antibodies). NDRG2 overexpression in myoblasts led to reduced cell proliferation and delayed cell cycle withdrawal during differentiation.
Electroacupuncture administration can alleviate reference memory deficits and suppress N-myc downstream-regulated gene 2 upregulation in an AD transgenic mouse model
NDRG2 expression decreased in adriamycin resistance breast cancer cells. NDRG2 can promote adriamycin sensitivity by inhibiting proliferation, enhancing cellular damage responses, and promoting apoptosis in a p53 (show TP53 Antibodies)-dependent manner.
Authors investigate the clinical and pathological role of NDRG2 in human malignant tumors. The absence of NDRG2 expression is associated with oncogenic properties through the loss of its role as a tumor suppressor; NDRG2 overexpression inhibits proliferation, adhesion, and invasion, whereas its expression is low or undetectable in various cancers. [Review]
These findings indicate that SUMOylation of NDRG2 is necessary for its tumor suppressor function in lung adenocarcinoma and that RNF4 (show RNF4 Antibodies) increases the efficiency of this process.
putative tumor suppressive function of NDRG2 may be confined to luminal- and basal B-type breast cancers
Overexpression of NDRG2 can inhibit the proliferation.
present results suggest that hypermethylation in promoter around exon 2 is functioning as essential factors of NDRG2 silencing in gastrointestinal cancers
NDRG2 overexpression significantly reduced hepatoma cell proliferation and enhanced cell apoptosis under glucose limitation. Moreover, NDRG2 overexpression aggravated energy imbalance and oxidative stress by decreasing the intracellular ATP and NADPH (show NQO1 Antibodies) generation and increasing ROS (show ROS1 Antibodies) levels.
The methylation status of the NDRG2 promoter in PBMCs is a potential noninvasive biomarker to predict the severity of liver fibrosis.
This gene is a member of the N-myc downregulated gene family which belongs to the alpha/beta hydrolase superfamily. The protein encoded by this gene is a cytoplasmic protein that may play a role in neurite outgrowth. This gene may be involved in glioblastoma carcinogenesis. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined.
, NDRG family member 2
, N-myc downstream-regulated gene 2
, N-myc downstream regulated 2
, N-myc downstream-regulated gene 2 protein
, protein Ndr2
, N-myc downstream regulator 2
, NDR1-related protein NDR2
, cytoplasmic protein Ndr1
, syld709613 protein
, N-myc downstream regulated gene 2
, NDRG1-related protein
, antidepressant-related protein ADRG123
, N-Myc downstream regulated gene 2